12/19
05:38 pm
orka
Form 4 Oruka Therapeutics, Inc. For: Dec 19 Filed by: Goncalves Joana
Low
Report
Form 4 Oruka Therapeutics, Inc. For: Dec 19 Filed by: Goncalves Joana
12/19
04:20 pm
orka
Form 144 Oruka Therapeutics, Inc. Filed by: Goncalves Joana
Low
Report
Form 144 Oruka Therapeutics, Inc. Filed by: Goncalves Joana
12/11
04:41 pm
orka
Form 4 Oruka Therapeutics, Inc. For: Dec 11 Filed by: Martin Christopher Nathan
Low
Report
Form 4 Oruka Therapeutics, Inc. For: Dec 11 Filed by: Martin Christopher Nathan
12/11
04:33 pm
orka
Form 3 Oruka Therapeutics, Inc. For: Dec 11 Filed by: Martin Christopher Nathan
Low
Report
Form 3 Oruka Therapeutics, Inc. For: Dec 11 Filed by: Martin Christopher Nathan
12/11
04:11 pm
orka
Form 8-K Oruka Therapeutics, Inc. For: Dec 11
Low
Report
Form 8-K Oruka Therapeutics, Inc. For: Dec 11
11/14
05:36 pm
orka
Form SCHEDULE 13G/A Oruka Therapeutics, Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.
Medium
Report
Form SCHEDULE 13G/A Oruka Therapeutics, Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.
11/12
04:04 pm
orka
Form 10-Q Oruka Therapeutics, Inc. For: Sep 30
Medium
Report
Form 10-Q Oruka Therapeutics, Inc. For: Sep 30
11/5
04:24 pm
orka
Form 424B5 Oruka Therapeutics, Inc.
Medium
Report
Form 424B5 Oruka Therapeutics, Inc.
11/5
04:24 pm
orka
Form 424B3 Oruka Therapeutics, Inc.
Medium
Report
Form 424B3 Oruka Therapeutics, Inc.
10/17
06:42 pm
orka
Form SCHEDULE 13G/A Oruka Therapeutics, Inc. Filed by: BlackRock, Inc.
Low
Report
Form SCHEDULE 13G/A Oruka Therapeutics, Inc. Filed by: BlackRock, Inc.
10/14
04:44 pm
orka
Form S-3/A Oruka Therapeutics, Inc.
Low
Report
Form S-3/A Oruka Therapeutics, Inc.
10/14
04:44 pm
orka
Form S-3/A Oruka Therapeutics, Inc.
Low
Report
Form S-3/A Oruka Therapeutics, Inc.
10/3
05:29 pm
orka
Form S-3 Oruka Therapeutics, Inc.
Medium
Report
Form S-3 Oruka Therapeutics, Inc.
10/3
05:20 pm
orka
Form S-3 Oruka Therapeutics, Inc.
Medium
Report
Form S-3 Oruka Therapeutics, Inc.
9/24
05:12 pm
orka
Form SCHEDULE 13G Oruka Therapeutics, Inc. Filed by: VIKING GLOBAL INVESTORS LP
Low
Report
Form SCHEDULE 13G Oruka Therapeutics, Inc. Filed by: VIKING GLOBAL INVESTORS LP